HOME >> BIOLOGY >> NEWS
Dana-Farber launches NFCR Center for Therapeutic Antibody Research and Engineering

BOSTONThe Dana-Farber Cancer Institute and the National Foundation for Cancer Research (NFCR) announced today the establishment of the NFCR Center for Therapeutic Antibody Engineering at Dana-Farber to assist scientists in developing new antibodies for cancer research. The new center, directed by Wayne Marasco, MD, PhD, of Dana-Farber, brings some of the most advanced research on antibody engineering together with the development of new therapies to combat cancer, the world's second leading cause of death.

With eight other NFCR research centers at universities and research hospitals worldwide, the NFCR Center at Dana-Farber will conduct therapeutic antibody research and provide high affinity human single-chain antibodies (sFv) to facilitate the ongoing cancer research of NFCR scientists. Many of the most promising anti-cancer drugs developed in recent years utilize humanized or human monoclonal antibodies Rituximab (anti-CD20); Herceptin (anti-Her2); Campath-H (anti-CD52). Other NFCR Centers have been established at Oxford, Yale, Penn State, University of California-Berkeley, University of Arizona, Freie Universitt Berlin, and the Institute of Medicinal Biotechnology in Beijing.

"This new initiative allows one of the world's strongest research programs at Dana-Farber to be networked into a collaborative partnership with NFCR scientists internationally. This collaborative effort adds a new dimension to NFCR's 'Laboratory Without Walls'," said Dr. Michael Wang, Director of Research at the National Foundation for Cancer Research in Bethesda, Maryland. "With this new NFCR Center for Therapeutic Antibody Engineering at Dana-Farber, we hope to create great synergies and multiple possibilities toward our goal of curing cancer."

How the Center Works

Traditionally, monoclonal antibodies have been derived from mouse models. However, this technique can produce Human Anti-mouse Antibody Responses (HAMA) when used clinically for human thera
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
13-Mar-2003


Page: 1 2 3

Related biology news :

1. Kinase backgrounder: Iressa discovery part of major kinase project at Dana-Farber
2. Dana-Farber launches Center for Applied Cancer Science
3. Dana-Farber scientists discover natural blocker of HIV-1 virus
4. Dana-Farber researchers to lead collaborative smallpox studies
5. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
6. Joslin Diabetes Center launches research section on developmental and stem cell biology
7. NIH launches first center in Nationwide Chemical Genomics Network
8. Biogeosciences.org launches
9. Clemson launches S.C. DNA Learning Center
10. STN International launches Derwent World Patents Index First View
11. JGI launches community sequencing program

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/5/2019)... TORONTO (PRWEB) , ... January 04, 2019 , ... ... Chief Architect – two experts in Healthcare & Life Sciences from MarkLogic – ... EST (4pm GMT). , This presentation outlines the challenges of using real world ...
(Date:1/4/2019)... ... January 03, 2019 , ... Over the last few years, ... discovery research workflows with biology ranging from single cell-type spheroids to highly complex ... studies, they create several challenges that need to be overcome in order to ...
(Date:12/27/2018)... ... December 27, 2018 , ... AxioMed completed its ... Boston facility, and is now raising growth capital to ramp up demand for ... against inferior ball and socket discs. The capital raise is targeted to qualified ...
Breaking Biology News(10 mins):
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... Leading authority ... an all-new, how-to guide with his “The Referral Playbook: How to Increase Sales ... of the book proceeds will go to the Alzheimer’s Foundation of America (AFA). ...
(Date:12/5/2018)... ... December 05, 2018 , ... STRmix™ – sophisticated forensic software ... – has been used to convict a Wyoming man of third-degree sexual assault, a ... used STRmix™ to test for DNA on the couch cushions on which the sexual ...
(Date:11/29/2018)... ... November 29, 2018 , ... RAGS, today announced the closing ... Seed Fund, with participation from existing investor and board member Jeremy Andrus, CEO of ... Cotopaxi. The additional funding will enable the company to accelerate its growth and expand ...
(Date:11/27/2018)... , ... November 27, 2018 , ... New patients in ... Dr. Dan Myers’ practice for treatment, with or without a referral. Dr. Myers has ... tools, including porcelain veneers, dental implants, bridges and custom crowns. , As a ...
Breaking Biology Technology:
Cached News: